Remove Develop Remove Enterprise Partners Remove San Diego Remove Technology
article thumbnail

TargeGen Acquired By Sanofi-aventis

socalTECH

San Diego-based TargeGen , a firm developing small molecule kinase inhibitors for the treatment of myelofibrosis (MF) and polycythemia vera (PV), has been acquired by Sanofi-aventis, in a deal worth as much as $560M, the firm said Wednesday. TargeGen had raised over $113M in venture funding from A.M.

article thumbnail

Q3 Southern California Venture Deals Around $879M

socalTECH

San Diego led investment activity in Q3, with a large number of the biggest VC deals all located in the area. Intellikine in La Jolla and Zogenix in San Diego both raised $51M in deals; San Diego's NextWave Wireless raised $45.5M, San Dieg's Roka BioScience $37.2M, and Borrego Solar Systems, in El Cajon, raised $30M.

article thumbnail

Scoperta Adds $1.4M

socalTECH

San Diego-based Scoperta , which is developing fabless specialty steel technology utilizing scrap materials, has raised $1.4M Other details on the funding have not been released, however, the firm is backed by Enterprise Partners and Vista Ventures, and Drew Senyei of Enterprise sits on the firm's board of directors.